Order Article Reprints

Strippoli S, Fanizzi A, Negri A, Quaresmini D, Nardone A, Armenio A, Sciacovelli AM, Massafra R, De Risi I, De Tullio G, et al. Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma. Cells. 2021; 10(2):406. https://doi.org/10.3390/cells10020406

Strippoli, Sabino, Annarita Fanizzi, Antonio Negri, Davide Quaresmini, Annalisa Nardone, Andrea Armenio, Angela Monica Sciacovelli, Raffaella Massafra, Ivana De Risi, Giacoma De Tullio, and et al. 2021. "Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma" Cells 10, no. 2: 406. https://doi.org/10.3390/cells10020406

Strippoli, S., Fanizzi, A., Negri, A., Quaresmini, D., Nardone, A., Armenio, A., Sciacovelli, A. M., Massafra, R., De Risi, I., De Tullio, G., Albano, A., & Guida, M. (2021). Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma. Cells, 10(2), 406. https://doi.org/10.3390/cells10020406